The largest database of trusted experimental protocols

Inveon preclinical imaging station

Manufactured by Siemens

The Inveon Preclinical Imaging Station is a versatile imaging platform designed for preclinical research. It provides high-resolution imaging capabilities for small animal studies. The system utilizes advanced imaging technologies to capture detailed visuals of various biological structures and processes.

Automatically generated - may contain errors

6 protocols using inveon preclinical imaging station

1

Imaging Tumor-Associated Myeloid Cells with PET/CT

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI was performed on all GL261 tumor-bearing mice (15–17 days post tumor cell injection) one day before PET/CT imaging to calculate tumor volume (~30 mm3). For PET/CT imaging, mice were injected intravenously with 89Zr-anti-CD11b (50 μg, 3.7 MBq; specific activity: 11.1 GBq/μmol for experimental group. To demonstrate CD11b-mediated tumor uptake, 89Zr-anti-CD11b (50 μg, 3.7 Mbq; specific activity: 11.1 GBq/μmol) was co-injected with 500 μg of anti-CD11b Ab to serve as blocking agent, which reduced specific activity 10-fold (1.1 GBq/μmol). Mice were anesthetized with 2% isoflurane, and static PET/CT imaging (Inveon Preclinical Imaging Station (Siemens Medical Solutions, Knoxville, TN) was performed 72 h post injection. Images were co-registered and analyzed using Inveon Research Workstation (IRW) software (version 4.2, Siemens Healthcare, Germany). Region of interest analysis was guided by CT. 89Zr-anti-CD11b Ab uptake is presented as SUVmean. Biodistribution studies of 89Zr-anti-CD11b Ab were performed in the same PET imaging cohort after 72 h PET/CT imaging. The mice were sacrificed after the PET/CT imaging and the major organs were collected weighed, and the tissue associated radioactivity was assessed in a gamma counter.
+ Open protocol
+ Expand
2

Multimodal Imaging and Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Radiochemistry reaction progress and purity were monitored using BIOSCAN ITLC (Eckert & Ziegler, Germany) and an Agilent 1260 infinity HPLC (Agilent Technologies, Santa Clara, CA) using Superose™ 12 10/300 GL SEC column (GE Healthcare, Chicago, IL). MRI data were acquired on a Bruker ClinScan 7 T MRI (Billerica, MA). Biodistribution samples were counted using a PerkinElmer 2470 WIZARD2 Automatic Gamma Counter (Waltham, MA). PET/CT data were acquired on an Inveon Preclinical Imaging Station (Siemens Medical Solutions, Knoxville, TN). Flow cytometry studies were performed on a BD LSRII (BD Biosciences, San Jose, CA), and data were analyzed using FlowJo software (BD Biosciences). IHC and hematoxylin and eosin (H&E) images were acquired using a Leica DFC7000T microscope (Leica Microsystems Inc).
+ Open protocol
+ Expand
3

Radiolabeled DOTA-PEG Peptide Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO), unless otherwise specified. Aqueous solutions were prepared using ultrapure water (resistivity, 18.2 MΩ·cm). Rink amide 4-methylbenzhydrylamine resin (loading, 0.77 mmol/g), and all Fmoc-protected amino acid were purchased from Chem-Impex International, Inc. (Wood Dale, IL). DOTA was purchased from CheMatec (Dijon, France). Fmoc-PEG4 carboxylic acid was purchased from ChemPep Inc. (Wellington, FL). 177LuCl3 was purchased from the University of Missouri Research Reactor Center (Columbia, MO). Analytical and semipreparative reversed-phase high-performance liquid chromatography (HPLC) were performed on a Waters 1525 Binary HPLC pump (Milford, MA) with a Waters 2489 UV–vis detector and a model 106 Bioscan radioactivity detector (Bioscan Inc., Washington, DC). Nonradioactive HPLC samples were analyzed on an analytical Jupiter C18 column and purified on a semipreparative Jupiter C18 column (Phenomenex, Torrance, CA). Radiochemistry reaction progress and purity were monitored on a Jupiter C18 column (Phenomenex, Torrance, CA). Radioactive samples were counted using either an automated Packard Cobra II gamma counter (Packard, Ramsey, MN) or a PerkinElmer 2470 WIZARD2 Automatic Gamma Counter (Waltham, MA). PET/CT data were acquired using an Inveon Preclinical Imaging Station (Siemens Medical Solutions).
+ Open protocol
+ Expand
4

Characterization of Synthesized Polymers

Check if the same lab product or an alternative is used in the 5 most similar protocols
1H NMR spectrum (400.0 MHz) was recorded on a Varian 400 FT-NMR spectrometer with CDCI3 as the solvent. Molecular weights (Mn and Mw) and molecular weight distributions (Mw/Mn) of the synthesized polymers were determined by gel permeation chromatography (GPC) equipped with a Waters 2414 refractive index detector. THF was used as the eluent with a flowing rate of 1.0 mL/min at 35°C. A series of polystyrene standards with narrow molecular weight distribution were applied for calibration. HPLC and FPLC were performed on a Waters 1525 Binary HPLC pump (Milford, MA) with a Waters 2489 UV/visible detector and a model 106 Bioscan radioactivity detector for the analysis of either 64Cu or 89Zr labeled conjugates using either a two-components buffer (0.1 v% TFA in de-ionized water + 0.1 v% TFA in acetonitrile) or PBS as the eluting phase for HPLC and FPLC respectively. PET/CT data were acquired using an Inveon Preclinical Imaging Station (Siemens Medical Solutions).
+ Open protocol
+ Expand
5

Analytical and Preparative HPLC Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analytical and semi-preparative reversed-phase high-performance liquid chromatography (HPLC) were performed on a Waters 1525 Binary HPLC pump (Milford, MA) with a Waters 2489 UV/visible detector and a model 106 Bioscan radioactivity detector (Bioscan inc., Washington, DC). Non-radioactive HPLC samples were analyzed on an analytical Jupiter C18 column and purified on a semi-preparative Jupiter C18 column (Phenomenex, Torrance, CA). Radiochemistry reaction progress and purity were monitored on a Jupiter C18 column (Phenomenex, Torrance, CA) or TLC scanner (Bioscan System 200; Eckert & Ziegler, Hopkinton, MA). PET/CT data were acquired using a small animal Inveon Preclinical Imaging Station (Siemens Medical Solutions, Knoxville, TN).
+ Open protocol
+ Expand
6

Radiolabeled Peptide Conjugate Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals were purchased from Sigma–Aldrich Chemical Co. (St. Louis, MO), unless otherwise specified. Aqueous solutions were prepared using ultrapure water (resistivity, 18 M). Copper-64 was obtained from Washington University (St. Louis, MO) and the University of Wisconsin (Madison, WI). A Model Cobra II gamma counter (PerkinElmer (Packard)) and a Model 2470 Wizard automatic gamma counter (PerkinElmer, Waltham, MA, USA) were used to measure γ radiation. 1H NMR and 13C NMR spectra were recorded on a Bruker DRX 400 MHz spectrometer (Billerica, MA), and electron-spray ionization mass spectroscpy (ESI-MS) spectra were measured on a Model LCT-Premier XE LC-MS station (Waters Corp., Milford, MA, USA). High-performance liquid chromatography (HPLC) columns (Model Luna C-18, Phenomenex, Torrance, CA, USA) were obtained. HPLC analyses were performed on a binary HPLC pump (Model 1525, Waters Corp., Milford, MA, USA) with an ultraviolet–visible-light (UV-vis) detector (Model 2489, Waters Corp., Milford, MA, USA) and a radioactivity detector (Model 106, Bioscan) for purification of some peptide conjugates and analysis of their 64Cu-labeled conjugates using two elution buffers (0.1 vol % TFA in deionized water as elution buffer A and 0.1 vol % TFA in acetonitrile as elution buffer B). PET/CT data were acquired using an Inveon Preclinical Imaging Station (Siemens Medical Solutions).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!